ViralClear submits investigational New Drug Application to FDA for phase II clinical trials for merimepodib
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…
Baxter obtained FDA Emergency Use Authorization for Oxiris blood purification filter for COVID-19 treatment
On Apr. 23, 2020, Baxter announced it had received emergency use authorization (EUA) from the FDA for the…
The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
NIAID strategic plan detailed COVID-19 research priorities
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
Oxford University COVID-19 vaccine began human trial stage
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
Oxford University Government began collaboration to track Covid-19 in UK population launched
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
AstraZeneca and Saint Lukeï¾’s Mid America Heart Institute initiated phase III DARE-19 trial with Farxiga in COVID-19 patients
On Apr. 23, 2020, AstraZeneca and and Saint Lukeï¾’s Mid America Heart Institute initiated a randomised, global Phase…
Oxford University and Guangdong Centre for Diseases Control and Prevention use virus genomic tracking to reveal rise and fall of COVID-19 epidemic
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
Key nose cells identified as likely COVID-19 entry points
On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…
TGen contributed to international studies identifying cell-types susceptible to SARS-CoV-2 infection
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
Yale launched clinical trial for drug to treat severe COVID-19 patients
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
Brensocatib (formerly INS1007) to be studied in patients with severe COVID-19 in investigator-initiated trial
On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…
Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
Roswell Park and Partners announced new Western New York Immunogenomic COVID-19 Study
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
The USDA confirmed COVID-19 in two pet cats in New York
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19
On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…
SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
Tyson Foods indefinitely suspended operations in Waterloo, Iowa
On Apr. 22, 2020, Tyson Fresh Meats, the beef and pork subsidiary of Tyson Food, planned to indefinitely…
Researchers identified cells likely targeted by COVID-19 virus
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchers
On Apr. 22, 2020, Engineers at the McKelvey School of Engineering at Washington University in St. Louis announced…
LabCorp broadened availability of COVID-19 serological antibody tests to hospitals and healthcare organizations
On Apr. 22, 2020, LabCorp announced expanded serological testing for SARS-CoV-2, the virus that causes COVID-19, to more…
BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidates
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
Virginia Tech researchers developed new COVID-19 tests to combat backlogs, shortages
On Apr. 22, 2020, Virginia Tech scientists annunced they had developed a new COVID-19 test and secured federal…
Cocrystal Pharma expanded exclusive license agreement with Kansas State University Research Foundation to new Coronavirus antiviral compound
On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…
FDA granted ALung Emergency Use Authorization to Hemolung Respiratory Assist System for treatment of COVID-19
On Apr. 22, 2020, ALung Technologies announced the U.S. Food and Drug Administration (FDA) granted the Company Emergency…
Bayer partnered with Population Health Research Institute on global clinical research evaluating COVID-19 treatments
On Apr. 21, 2020, Bayer Mississauga, Ontario announced a partnership with the Population Health Research Institute (PHRI) to…
Expert US panel developed NIH treatment guidelines for COVID-19
On Apr. 21, 2020, A panel of U.S. physicians, statisticians, and other experts developed treatment guidelines for coronavirus…